|
1.
|
2025/06/04
|
|
NK cell cytotoxicity is markedly reduced in younger patients with rheumatoid arthritis treated with JAK inhibitors
|
|
2.
|
2025/06/02
|
|
Switching to IL-6 inhibitors or abatacept in elderly patients with rheumatoid arthritis achieving low disease activity with jak inhibitors: a pilot study
|
|
3.
|
2025/05/22
|
|
Coexistence of IgG4-Related Disease and Renal Anastomosing Hemangioma: A Rare Diagnostic Challenge
|
|
4.
|
2025/02/26
|
|
Clinical Significance of Antinuclear Antibodies in Patients with Rheumatoid Arthritis: From SETOUCHI-RA Registry
|
|
5.
|
2025/02/19
|
|
Case Report: Effective Management of Pulmonary Hypertension Associated With Takayasu Arteritis Through Both Immunosuppressive Therapy and Serial Balloon Pulmonary Angioplasty
|
|
6.
|
2024/03/21
|
|
Prognosis and prognostic factors of lung cancer complications in patients with rheumatoid arthritis
|
|
7.
|
2024/01/31
|
|
GWAS for systemic sclerosis identifies six novel susceptibility loci including one in the Fcγ receptor region
|
|
8.
|
2023/10/03
|
|
Computed tomography for malignancy screening in patients with rheumatoid arthritis before initiation of disease modifying antirheumatic drug
|
|
9.
|
2022/11/15
|
|
Acromegaly: A Rare Cause of Knee Pain
|
|
10.
|
2022/09/16
|
|
Role of DNA dioxygenase Ten-Eleven translocation 3 (TET3) in rheumatoid arthritis progression
|
|
11.
|
2022/07/22
|
|
TRAPS mutations in Tnfrsf1a decrease the responsiveness to TNFα via reduced cell surface expression of TNFR1
|
|
12.
|
2022/05/14
|
|
IL-17A promotes vascular calcification in an ex vivo murine aorta culture
|
|
13.
|
2022/03/10
|
|
IL-17A promotes vascular calcification in an ex vivo murine aorta culture
|
|
14.
|
2022/03/04
|
|
Short-Term Prognostic Factors in Hospitalized Herpes Zoster Patients and Its Associated Cerebro-Cardiovascular Events: A Nationwide Retrospective Cohort in Japan
|
|
15.
|
2020/08/20
|
|
A case of systemic lupus erythematosus in which Cushing’s syndrome caused by adrenal adenoma accidentally occurred during long-term maintenance therapy with corticosteroids.
|
|
16.
|
2020/06/15
|
|
Favorable efficacy of rituximab in ANCA-associated vasculitis patients with excessive B cell differentiation.
|
|
17.
|
2020/06/08
|
|
Differential long-term retention of biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis by age group from the FIRST registry.
|
|
18.
|
2020/05/04
|
|
Two patients with mixed connective tissue disease complicated by pulmonary arterial hypertension showing contrasting responses to pulmonary vasodilators.
|
|
19.
|
2020/04/20
|
|
A case of bone destruction caused by chronic non-bacterial osteomyelitis (CNO) successfully repaired with a tumor necrosis factor-α (TNF-α) inhibitor, adalimumab.
|
|
20.
|
2020/03/27
|
|
Clinical aspects in patients with rheumatoid arthritis complicated with lymphoproliferative disorders without regression after methotrexate withdrawal and treatment for arthritis after regression of lymphoproliferative disorders.
|
|
21.
|
2020/03/12
|
|
Systemic lupus erythematosus with repeated protein-losing enteropathy resulting from different pathological conditions: a case report.
|
|
22.
|
2020/03/01
|
|
IgG4-type Multiple Myeloma with Diffuse Enlargement of the Thyroid Requiring Differentiation from IgG4-related Disease.
|
|
23.
|
2020/02/05
|
|
Correlation between serological biomarkers of extracellular matrix turnover and lung fibrosis and pulmonary artery hypertension in patients with systemic sclerosis.
|
|
24.
|
2020/02/05
|
|
The additive effects of hydroxychloroquine to maintenance therapy with standard of care in patients with systemic lupus erythematosus.
|
|
25.
|
2020/01/15
|
|
5-year remission rate after the discontinuation of adalimumab in patients with rheumatoid arthritis: Long-term follow-up results of the HONOR study.
|
|
26.
|
2020/01/07
|
|
2019 Diagnostic criteria for mixed connective tissue disease (MCTD): From the Japan research committee of the ministry of health, labor, and welfare for systemic autoimmune diseases.
|
|
27.
|
2019/12/01
|
|
Distinctive association of peripheral immune cell phenotypes with capillaroscopic microvascular patterns in systemic sclerosis.
|
|
28.
|
2019/11/22
|
|
An autopsy case of a patient with systemic sclerosis who developed marked pulmonary hypertension becase of pulmonary tumor thrombotic microangiopathy caused by gastric carcinoma.
|
|
29.
|
2019/10/19
|
|
Sustained discontinuation of infliximab with a raising-dose strategy after obtaining remission in patients with rheumatoid arthritis: the RRRR study, a randomised controlled trial.
|
|
30.
|
2019/08/21
|
|
Focal Eosinophilic Myositis.
|
|
31.
|
2019/06/22
|
|
Comparative study of corticosteroid monotherapy, and TNF inhibitors with or without corticosteroid in patients with refractory entero-Behcet's disease.
|
|
32.
|
2019/06
|
|
IL-6 and sIL-6R induces STAT3-dependent differentiation of human VSMCs into osteoblast-like cells through JMJD2B-mediated histone demethylation of RUNX2.
|
|
33.
|
2019/03/01
|
|
An Autopsy Case with Cerebral Hemorrhaging due to disseminated Aspergillosis During Glucocorticoid Therapy for Overlap Syndrome of Systemic Lupus Erythematosus and Systemic Sclerosis.
|
|
34.
|
2019/03
|
|
Effectiveness and safety of hydroxychloroquine therapy with or without corticosteroid in patients with systemic lupus erythematosus.
|
|
35.
|
2019/03
|
|
Type I and II interferons commit to abnormal expression of chemokine receptor on B cells in patients with systemic lupus erythematosus.
|
|
36.
|
2019/02/15
|
|
Fatal Chronic Active Epstein-Barr Virus Infection in a Rheumatoid Arthritis Patient Treated with Abatacept.
|
|
37.
|
2019/02/01
|
|
Precision medicine using different biological DMARDs based on characteristic phenotypes of peripheral T helper cells in psoriatic arthritis.
|
|
38.
|
2019/02/01
|
|
Small Cell Lung Cancer Patient with Anti-transcriptional Intermediary Factor 1γ Antibody Who Developed Dermatomyositis after Successful Chemoradiotherapy.
|
|
39.
|
2019/01/09
|
|
The two cases of Acute acalculous cholecystitis associated with Systemic Lupus Erythematosus(SLE) presented different clinical aspects.
|
|
40.
|
2019/01/01
|
|
Significance of nailfold videocapillaroscopy in patients with idiopathic inflammatory myopathies.
|
|
41.
|
2018/12/10
|
|
Th22 Cells Promote Osteoclast Differentiation via Production of IL-22 in Rheumatoid Arthritis.
|
|
42.
|
2018/10/26
|
|
Relevance of interferon-gamma in pathogenesis of life-threatening rapidly progressive interstitial lung disease in patients with dermatomyositis.
|
|
43.
|
2018/08/28
|
|
Up-Regulation of TLR7-Mediated IFN-α Production by Plasmacytoid Dendritic Cells in Patients With Systemic Lupus Erythematosus.
|
|
44.
|
2018/08/01
|
|
IgG4-related Pleuritis with Elevated Adenosine Deaminase in Pleural Effusion: A Case Report.
|
|
45.
|
2018/06/01
|
|
Successful Management of Pregnancy in a Patient with Systemic Lupus Erythematosus-associated Pulmonary Arterial Hypertension.
|
|
46.
|
2018/06
|
|
A case of refractory lupus nephritis complicated by psoriasis vulgaris that was controlled with secukinumab
|
|
47.
|
2018/06
|
|
Comparison of efficacy of TNF inhibitors and abatacept in patients with rheumatoid arthritis; Adjusted with propensity score matching.
|
|
48.
|
2018/06
|
|
Evaluation of the alternative classification criteria of systemic lupus erythematosus established by Systemic Lupus International Collaborating Clinics (SLICC).
|
|
49.
|
2018/05/17
|
|
Successful treatment with etanercept in a case of seronegative rheumatoid arthritis with corticosteroid/methotrexate-resistant pemphigus erythematosus.
|
|
50.
|
2018/03/01
|
|
Correlation of T follicular helper cells and plasmablasts with the development of organ involvement in patients with IgG4-related disease.
|
|
51.
|
2018/01/01
|
|
Differential effects of biological DMARDs on peripheral immune cell phenotypes in patients with rheumatoid arthritis.
|
|
52.
|
2018
|
|
High level of adenosine deaminase in pleural effusion in patient with IgG4-related disease: A case report.
|
|
53.
|
2017/12
|
|
Relapsing Polychondritis Diagnosed by Fusion Images of Gallium-67 Uptake on Computed Tomography and Single-Photon-Emission Computed Tomography.
|
|
54.
|
2017/11/08
|
|
Genome-wide Association Study of Idiopathic Osteonecrosis of the Femoral Head.
|
|
55.
|
2017/09/01
|
|
Induction of Regulatory T Cells and Its Regulation with Insulin-like Growth Factor/Insulin-like Growth Factor Binding Protein-4 by Human Mesenchymal Stem Cells.
|
|
56.
|
2017
|
|
A case of rheumatoid arthritis treated with infliximab who developed disseminated Penicillium marneffei infection after visit to Thailand.
|
|
57.
|
2017
|
|
Peripheral immunophenotyping identifies three subgroups based on T cell heterogeneity in lupus patients.
|
|
58.
|
2017
|
|
The occurrence of hypertrophic pachymeningitis with infiltration of IgG4-positive plasma cells and with different aetiology: report of three cases.
|
|
59.
|
2016/08/31
|
|
Clinical, radiographic and functional efficacy of abatacept in routine care for rheumatoid arthritis patients: Abatacept Leading Trial for RA on Imaging Remission (ALTAIR) study.
|
|
60.
|
2016
|
|
Comparison of the efficacies of abatacept and tocilizumab in patients with rheumatoid arthritis by propensity score matching.
|
|
61.
|
2015/07/31
|
|
Histamine inhibits differentiateon of skin fibroblasts into myofibroblasts.
|
|
62.
|
2015/05
|
|
IL-6/STAT3 signaling pathway contributes to chondrogenic differentiation of human mesenchymal stem cells.
|
|
63.
|
2015/02
|
|
Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study.
|
|
64.
|
2014/05
|
|
Study on the safety and efficacy of tocilizumab, an anti-IL-6 receptor antibody, in patients with rheumatoid arthritis complicated with AA amyloidosis.
|
|
65.
|
2013/09/25
|
|
Discontinuation of adalimumab after attaining disease activity score 28-erythrocyte sedimentation rate remission in patients with rheumatoid arthritis (HONOR study): an observational study.
|
|
66.
|
2013/07
|
|
D1-like dopamine receptors antagonist inhibits cutaneous immune reactions mediated by Th2 and mast cells.
|
|
67.
|
2013/02/01
|
|
Regulation of DNA Methylation in Rheumatoid Arthritis Synoviocytes.
|
|
68.
|
2013/01
|
|
DNA methylome signature in rheumatoid arthritis.
|
|
69.
|
2013
|
|
Dopamine D2-like receptor signaling suppresses human osteoclastogenesis.
|
|
70.
|
2012/10
|
|
Interleukin-1β induces differentiation of human mesenchymal stem cells into osteoblasts via the Wnt-5a/receptor tyrosine kinase-like orphan receptor 2 pathway.
|
|
71.
|
2012/06
|
|
Amplification of Toll-like receptor-mediated signaling through spleen tyrosine kinase in human B-cell activation.
|
|
72.
|
2012
|
|
The JAK inhibitor tofacitinib regulates synovitis through inhibition of IFN-γ and IL-17 production by human CD4(+) T cells.
|
|
73.
|
2011/06
|
|
Human mesenchymal stem cells inhibit osteoclastogenesis through osteoprotegerin production.
|
|
74.
|
2011/06
|
|
Therapeutic effect of D1-like dopamine receptor antagonist on collagen-induced arthritis of mice.
|
|
75.
|
2011/05/15
|
|
Dopamine D1-like receptor antagonist attenuates Th17-mediated immune response and ovalbumin antigen-induced neutrophilic airway inflammation.
|
|
76.
|
2011/03/15
|
|
Dopamine induces IL-6-dependent IL-17 production via D1-like receptor on CD4 naive T cells and D1-like receptor antagonist SCH-23390 inhibits cartilage destruction in a human rheumatoid arthritis/SCID mouse chimera model.
|
|
77.
|
2010/03
|
|
Tacrolimus, a calcineurin inhibitor, overcomes treatment unresponsiveness mediated by P-glycoprotein on lymphocytes in refractory rheumatoid arthritis.
|
|
78.
|
2009/06
|
|
Dopamine released by dendritic cells polarizes Th2 differentiation.
|
|
79.
|
2008/08/22
|
|
Antagonizing dopamine D1-like receptor inhibits Th17 cell differentiation: preventive and therapeutic effects on experimental autoimmune encephalomyelitis.
|
|
80.
|
2008/07/01
|
|
B cell chemoattractant CXCL13 is preferentially expressed by human Th17 cell clones.
|
|
81.
|
2008/02
|
|
Interaction of galectin-9 with lipid rafts induces osteoblast proliferation through the c-Src/ERK signaling pathway.
|
|
82.
|
2007/06/29
|
|
Notch ligand mRNA levels of human APCs predict Th1/Th2-promoting activities.
|
|
83.
|
2007/05
|
|
Activation signal transduction by beta1 integrin in T cells from patients with systemic lupus erythematosus.
|
|
84.
|
2007/04
|
|
Rheumatoid synovial endothelial cells produce macrophage colony-stimulating factor leading to osteoclastogenesis in rheumatoid arthritis.
|
|
85.
|
2007/01
|
|
Engagement of CD44 up-regulates Fas ligand expression on T cells leading to activation-induced cell death.
|
|
86.
|
2005/06
|
|
Clinical relevance of the expression of P-glycoprotein on peripheral blood lymphocytes to steroid resistance in patients with systemic lupus erythematosus.
|
|
87.
|
2004/12
|
|
Transcriptional regulation of multidrug resistance-1 gene by interleukin-2 in lymphocytes.
|
|
88.
|
2004/08
|
|
Induction of RANKL expression and osteoclast maturation by the binding of fibroblast growth factor 2 to heparan sulfate proteoglycan on rheumatoid synovial fibroblasts.
|
|
89.
|
2004/07
|
|
Macrophage inflammatory protein-1alpha induces hypercalcemia in adult T-cell leukemia.
|
|
90.
|
2004
|
|
Follistatin-related protein gene (FRP) is expressed in the synovial tissues of rheumatoid arthritis, but its polymorphisms are not associated with genetic susceptibility.
|
|
91.
|
2003/03/27
|
|
Crosslinking of CD44 on human osteoblastic cells upregulates ICAM-1 and VCAM-1.
|
|
92.
|
2001/06
|
|
Multiple hepatic infarction after transcatheter arterial infusion with SMANCS.
|
|
Display 5 items
|
|
Display all(92)
|
